Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
The Lancet. Oncology|April 2, 2026
Ifinatamab deruxtecan, a B7-H3-directed antibody-drug conjugate, in patients with advanced solid tumours (IDeate-PanTumor01): dose-escalation results from a phase 1/2 trialMelissa L Johnson, Manish R Patel, Gerald S Falchook, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
A Phase I Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose EscalationFlorence Atrafi, Oliver Boix, Vivek Subbiah, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2021
Stratification of Patients With Sjögren's Syndrome and Patients With Systemic Lupus Erythematosus According to Two Shared Immune Cell Signatures, With Potential Therapeutic ImplicationsLucia Martin-Gutierrez, Junjie Peng, Nicolyn L Thompson, et al.
Ophthalmology. Retina|January 14, 2024
Spectrum of Genetic Variants in the Most Common Genes Causing Inherited Retinal Disease in a Large Molecularly Characterized United Kingdom CohortSiying Lin, Sandra Vermeirsch, Nikolas Pontikos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib StudyEdward S Kim, Karen Kelly, Luis G Paz-Ares, et al.
Journal for Immunotherapy of Cancer|October 19, 2021
Avelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trialJoël Guigay, Keun-Wook Lee, Manish R Patel, et al.
Blood|December 6, 2017
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemiaChristine Chen, David Siegel, Martin Gutierrez, et al.
British Journal of Clinical Pharmacology|August 1, 2020
The effect of sonidegib (LDE225) on the pharmacokinetics of bupropion and warfarin in patients with advanced solid tumoursDarcy B Pooler, Dylan B Ness, John Sarantopoulos, et al.
Lung Cancer (Amsterdam, Netherlands)|August 9, 2021
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancerByoung Chul Cho, Kiyotaka Yoh, Ruth Perets, et al.
The Oncologist|July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid TumorsKhanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Pageof 13